Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 5Colorectal Neoplasms 5Sarcoma 2Endometrial Neoplasms 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Postoperative Complications 1Pancreatectomy 1Ovarian Neoplasms 1Neoplasms 1Motor Activity 1Lymphoma, Follicular 1Lung Neoplasms 1Heart Defects, Congenital 1Gynecologic Surgical Procedures 1Gynecologic Cancer 1Gastrointestinal Neoplasms 1Frailty 1Coma 1Colonic Neoplasms 1Cerebrovascular Disorders 1Carcinoma, Hepatocellular 1Brain Injuries, Traumatic 1

Interventions

Oxaliplatin 18Surveys and Questionnaires 15Fluorouracil 15Capecitabine 13Leucovorin 12Blood Specimen Collection 11Irinotecan 10Standard of Care 7Cisplatin 7Endoscopic Mucosal Resection 6atezolizumab 5Specimen Handling 5Radiotherapy 5Educational Status 5Drug Therapy 5Docetaxel 5S 1 (combination) 4Radiosurgery 4Nivolumab 4Magnetic Resonance Spectroscopy 4Interviews as Topic 4Gemcitabine 4Everolimus 4Colonoscopy 4Biopsy 4Bevacizumab 4tegafur-gimeracil-oteracil 3pemigatinib 3apatinib 3Remote Patient Monitoring 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Gastrointestinal Neoplasms × Enhanced Recovery After Surgery × Clear all
NCT04201730 2021-09-21

Study on the Efficacy and Safety of Enhanced Recovery After Surgery (ERAS)in Gastrointestinal Cancer

Huashan Hospital

Phase NA Completed
356 enrolled
Gastrointestinal

Gastrointestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡